Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
Dario Neri
Cancer Immunology Research (2019) Vol. 7, Iss. 3, pp. 348-354
Open Access | Times Cited: 127

Showing 26-50 of 127 citing articles:

Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity
Wenqiang Shi, Nan Liu, Zexin Liu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101531-101531
Open Access | Times Cited: 6
Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies
Ladislav Šenolt
F1000Research (2019) Vol. 8, pp. 1549-1549
Open Access | Times Cited: 48
A novel co-culture assay to assess anti-tumor CD8+ T cell cytotoxicity via luminescence and multicolor flow cytometry
Verónica Olivo Pimentel, Ala Yaromina, Damiënne Marcus, et al.
Journal of Immunological Methods (2020) Vol. 487, pp. 112899-112899
Open Access | Times Cited: 43
Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
Bettina Sehnert, Harald Burkhardt, Stefan Dübel, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1627-1627
Open Access | Times Cited: 41
Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
Xiaotian Zhong, Aaron M. D’Antona
Antibodies (2021) Vol. 10, Iss. 2, pp. 13-13
Open Access | Times Cited: 34
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
Tomohiro Fujii, Yutaka Matsuda
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 11, pp. 1053-1065
Closed Access | Times Cited: 14
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice
Carmine Carbone, R. De Luca, Emanuele Puca, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Developing anti-TDE vaccine for sensitizing cancer cells to treatment and metastasis control
Stephene S. Meena, Benson Kiprono Kosgei, Geofrey F. Soko, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Advances in Cancer Gene Therapy: Strategies, Delivery Methods, and Challenges
Anni Lepland, Kadi-Liis Veiman
Methods in pharmacology and toxicology (2025), pp. 105-123
Closed Access
Causal associations of inflammatory cytokines and urinary stones: a two-sample Mendelian randomization study
Huan Yao, Dan Yu, Qingyun He, et al.
Translational Andrology and Urology (2025) Vol. 14, Iss. 2, pp. 258-265
Open Access
Bifunctional Phagocytic Synapse Enhancers for Cancer Immunotherapy
Valerio Sabatino, Silvan Fleisch, Cong Tang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
Verónica Olivo Pimentel, Damiënne Marcus, Alexander MA van der Wiel, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 3, pp. e001764-e001764
Open Access | Times Cited: 32
Potential application of immunotherapy for modulation of pulp inflammation: opportunities for vital pulp treatment
Shelly Arora, Paul R. Cooper, Lara T. Friedlander, et al.
International Endodontic Journal (2021) Vol. 54, Iss. 8, pp. 1263-1274
Open Access | Times Cited: 31
Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials
Fan Tang, Yan Tie, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188606-188606
Open Access | Times Cited: 31
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand
Nicola Zambrano, Guendalina Froechlich, Dejan Lazarević, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1325-1325
Open Access | Times Cited: 20
Generation andin vivovalidation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody
Lisa Nadal, Frederik Peissert, Abdullah Elsayed, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e005282-e005282
Open Access | Times Cited: 20
Facts and Hopes: Immunocytokines for Cancer Immunotherapy
Aliyah Pabani, Justin F. Gainor
Clinical Cancer Research (2023) Vol. 29, Iss. 19, pp. 3841-3849
Closed Access | Times Cited: 11
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
Solange Peters, Eric Angevin, Teresa Alonso‐Gordoa, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 8, pp. 1630-1641
Closed Access | Times Cited: 4
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors
Giulia Rotta, Ettore Gilardoni, Domenico Ravazza, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 904-926
Open Access | Times Cited: 4
The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody
Sheena N. Smith, Rajib Schubert, Branko Simic, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 21
Open Access | Times Cited: 25
Interleukin 2-Based Fusion Proteins for the Treatment of Cancer
Alana MacDonald, T.‐C. Wu, Chien‐Fu Hung
Journal of Immunology Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 25
Mini-review: The market growth of diagnostic and therapeutic monoclonal antibodies – SARS CoV-2 as an example
Yasmine S. El, Ashraf A. Tabll, Robert Smolić, et al.
Human Antibodies (2021) Vol. 30, Iss. 1, pp. 15-24
Open Access | Times Cited: 25
A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity
Wenqiang Shi, Liangyin Lv, Nan Liu, et al.
Molecular Therapy (2022) Vol. 31, Iss. 1, pp. 66-77
Open Access | Times Cited: 17
Immunostimulatory CKb11 gene combined with immune checkpoint PD-1/PD-L1 blockade activates immune response and simultaneously overcomes the immunosuppression of cancer
Wen Nie, Yihong He, Xue Mi, et al.
Bioactive Materials (2024) Vol. 39, pp. 239-254
Open Access | Times Cited: 3
Understanding the Dynamics of Inflammatory Cytokines in Endodontic Diagnosis: A Systematic Review
Ignacio Barbero-Navarro, María Esther Irigoyen‐Camacho, Marco Antonio Zepeda‐Zepeda, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1099-1099
Open Access | Times Cited: 3

Scroll to top